Skip to Main Content

Skip Nav Destination

Article navigation

Commentary| June 01 2004

Staff Resources Speed FDA Drug Review: A Critical Analysis of the Returns to Resources in Approval Regulation

Daniel Carpenter

Daniel Carpenter

Search for other works by this author on:

Google

J Health Polit Policy Law (2004) 29 (3): 431–442.

https://doi.org/10.1215/03616878-29-3-431

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.